Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT01223027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of Dovitinib versus sorafenib in patients with metastatic renal cell cancer.
Study identification
- NCT ID
- NCT01223027
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 564 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2011 (Type not available)
- Primary completion
- Jun 2014 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Dec 7, 2015
2011 – 2014
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group Dept of Highlands Oncology Grp | Fayetteville | Arkansas | 72703 | — |
| University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) | La Jolla | California | 92093-0658 | — |
| Cedars Sinai Medical Center Cedars Sinai Medical Ctr. (SC) | Los Angeles | California | 90048 | — |
| University of California at Los Angeles UCLA (4) | Los Angeles | California | 90095 | — |
| Stanford University Medical Center Cancer Clinical Trials Office | Stanford | California | 94304 | — |
| Rocky Mountain Cancer Centers RMCC | Greenwood Village | Colorado | — | — |
| Florida Cancer Specialists DeptofFloridaCancerSpecialists | Fort Myers | Florida | 33901 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| Straub Clinic & Hospital Straub | Honolulu | Hawaii | 96813 | — |
| Moanalua Medical Center. Attn: Oncology Dept | Honolulu | Hawaii | 96817 | — |
| University of Kansas Cancer Center Univ of KS | Kansas City | Kansas | 66160 | — |
| University of Maryland Medical Center UMMC | Baltimore | Maryland | 21201 | — |
| Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) | Detroit | Michigan | 48201 | — |
| University of Minnesota Medical Center - Fairview Univ of MN | Minneapolis | Minnesota | 55455 | — |
| Comprehensive Cancer Centers of Nevada CCC of Nevada (1) | Las Vegas | Nevada | 89109 | — |
| CINJ at Cooper University Hospital Cooper | Voorhees Township | New Jersey | 08043 | — |
| Memorial Sloan Kettering Cancer Center Dept. of MSKCC | New York | New York | 90033 | — |
| SUNY - Upstate Medical University Div. of Hematology-Oncology | Syracuse | New York | 13210 | — |
| New York Oncology Hematology, P.C. Dept. of New York Oncology. PC | Troy | New York | 12180 | — |
| Willamette Valley Clinical Studies Williamette Valley Cancer | Eugene | Oregon | 97404 | — |
| St. Luke's Hospital and Health Network St Luke's | Bethlehem | Pennsylvania | — | — |
| Medical University of South Carolina -Hollings Cancer Center Med Univ SC | Charleston | South Carolina | 29425 | — |
| Cancer Centers of the Carolinas CC of C -Eastside | Greenville | South Carolina | 29605 | — |
| Sarah Cannon Research Institute SC - 3 | Chattanooga | Tennessee | 37404 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Vanderbilt University Medical Center SC | Nashville | Tennessee | 37232 | — |
| Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (4) | Dallas | Texas | 75246 | — |
| Texas Oncology Texas Onc - Austin | Dallas | Texas | 75251 | — |
| Texas Oncology Texas Oncology - Houston | Dallas | Texas | 75251 | — |
| University of Texas Southwestern Medical Center UTSW | Dallas | Texas | 75390-9034 | — |
| Deke Slayton Cancer Center Deke Slayton Cancer Center (2) | Webster | Texas | 77598 | — |
| Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) | Salt Lake City | Utah | 84106 | — |
| University of Virginia Health Systems Univ Virginia | Charlottesville | Virginia | 22908-0334 | — |
| Rockwood Clinic Spokane Location | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01223027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2015 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01223027 live on ClinicalTrials.gov.